Limonium Tetragonum Enhances Osteoblastogenesis while Suppressing the Adipocyte Differentiation |
Kim, Jung-Ae
(Marine Biotechnology Center for Pharmaceuticals and Foods, Silla University)
Ahn, Byul-Nim (Marine Biotechnology Center for Pharmaceuticals and Foods, Silla University) Oh, Jung Hwan (Marine Biotechnology Center for Pharmaceuticals and Foods, Silla University) Karadeniz, Fatih (Marine Biotechnology Center for Pharmaceuticals and Foods, Silla University) Lee, Jung Im (Marine Biotechnology Center for Pharmaceuticals and Foods, Silla University) Seo, Youngwan (Division of Marine Bioscience, Korea Maritime and Ocean University) Kong, Chang-Suk (Marine Biotechnology Center for Pharmaceuticals and Foods, Silla University) |
1 | Kawai M, Rosen CJ (2010) PPARγ: a circadian transcription factor in adipogenesis and osteogenesis. Nat Rev Endocrinol 6:629-636 DOI |
2 | Woo C, Gao G, Wade S, Hochberg MC (2010) Gastrointestinal side effects in postmenopausal women using osteoporosis therapy: 1-year findings in the POSSIBLE US study. Curr Med Res Opin 26:1003-1009 DOI |
3 | Yang MH, Kim NH, Heo JD, Sung SH, Jeong EJ (2014) Hepatoprotective effects of Limonium tetragonum, edible medicinal halophyte growing near seashores. Pharmacogn Mag 10: S563-S568 |
4 | Zhuang H, Zhang X, Zhu C, Tang X, Yu F, Shang WG, Cai X (2016) Molecular mechanisms of PPAR-γ; governing MSC osteogenic and adipogenic differentiation. Curr Stem Cell Res Ther 11:255-264 DOI |
5 | Bae MJ, Karadeniz F, Lee SG, Seo Y, Kong CS (2016) Inhibition of MMP-2 and MMP-9 Activities by Limonium tetragonum Extract. Prev Nutr Food Sci 21:38-43 DOI |
6 | Colaianni G, Brunetti G, Faienza MF, Colucci S, Grano M (2014) Osteoporosis and obesity: role of Wnt pathway in human and murine models. World J Orthop 5:242-246 DOI |
7 | Hu L, Yin C, Zhao F, Ali A, Ma J, Qian A (2018) Mesenchymal stem cells: cell fate decision to osteoblast or adipocyte and application in osteoporosis treatment. Int J Mol Sci 19:360 DOI |
8 | Kraenzlin ME, Meier C (2011) Parathyroid hormone analogues in the treatment of osteoporosis. Nat Rev Endocrinol 7:647-656 DOI |
9 | Xu C, Wang J, Zhu T, Shen Y, Tang X, Fang L, Xu Y (2016) Cross-talking between PPAR and WNT signaling and its regulation in mesenchymal stem cell differentiation. Curr Stem Cell Res Ther 11:247-254 DOI |
10 | Rizzoli R, Cooper C, Reginster JY, Abrahamsen B, Adachi JD, Brandi ML, Bruyere O, Compston J, Ducy P, Ferrari S, Harvey NC, Kanis JA, Karsenty G, Laslop A, Rabenda V, Vestergaard P (2012) Antidepressant medications and osteoporosis. Bone 51:606-613 DOI |
11 | Matsubara T, Kida K, Yamaguchi A, Hata K, Ichida F, Meguro H, Aburatani H, Nishimura R, Yoneda T (2008) BMP2 regulates Osterix through Msx2 and Runx2 during osteoblast differentiation. J Biol Chem 283:29119-29125 DOI |
12 | Wang C, Meng H, Wang X, Zhao C, Peng J, Wang Y (2016) Differentiation of bone marrow mesenchymal stem cells in osteoblasts and adipocytes and its role in treatment of osteoporosis. Med Sci Monit 22:226-233 DOI |
13 | Karadeniz F, Kim JA, Ahn BN, Kwon MS, Kong CS (2014) Effect of Salicornia herbacea on osteoblastogenesis and adipogenesis in vitro. Mar Drugs 12:5132-5147 DOI |
14 | Wan Y, Chong LW, Evans RM (2007) PPAR-γ regulates osteoclastogenesis in mice. Nat Med 13:1496-1503 DOI |
15 | Zhou BO, Yue R, Murphy MM, Peyer JG, Morrison SJ (2014) Leptin-receptor- expressing mesenchymal stromal cells represent the main source of bone formed by adult bone marrow. Cell Stem Cell 15:154-168 DOI |
16 | Bone HG, Mc Clung MR, Roux C, Rec ker RR, Eisman JA, Verbruggen N, Hustad CM, Da Silva C, Santora AC, Ince BA (2009) Odanacatib, a cathepsin-K inhibitor for osteoporosis: a two-year study in postmenopausal women with low bone density. J Bone Miner Res 25:34-41 |
17 | Golub EE, Boesze-Battaglia K (2007) The role of alkaline phosphatase in mineralization. Curr Opin Orthop 18:444-448 DOI |
18 | Guan M, Yao W, Liu R, Lam KS, Nolta J, Jia J, Panganiban B, Meng L, Zhou P, Shahnazari M, Ritchie RO, Lane NE (2012) Directing mesenchymal stem cells to bone to augment bone formation and increase bone mass. Nat Med 18:456-462 DOI |
19 | Ing SW, Belury MA (2011) Impact of conjugated linoleic acid on bone physiology: proposed mechanism involving inhibition of adipogenesis. Nutr Rev 69:123-131 DOI |
20 | James AW (2013) Review of signaling pathways governing MSC osteogenic and adipogenic differentiation. Scientifica 2013:684736 DOI |
21 | Watts NB, Diab DL (2010) Long-term use of bisphosphonates in osteoporosis. J Clin Endocrinol Metab 95:1555-1565 DOI |
22 | Lecka-Czernik B (2010) PPARs in bone: the role in bone cell differentiation and regulation of energy metabolism. Curr Osteoporos Rep 8:84-90 DOI |
23 | Lee JI, Kong CS, Jung ME, Hong JW, Noh I, Seo Y (2011) Peroxynitrite-scavenging activity of the halophyte Limonium tetragonum. Ocean Polar Res 33:185-191 DOI |
24 | Ominsky MS, Li C, Li X, Tan HL, Lee E, Barrero M, Asuncion FJ, Dwyer D, Han CY, Vlasseros F, Samadfam R, Jolette J, Smith SY, Stolina M, Lacey DL, Simonet WS, Paszty C, Li G, Ke HZ (2011) Inhibition of sclerostin by monoclonal antibody enhances bone healing and improves bone density and strength of nonfractured bones. J Bone Miner Res 26:1012-1021 DOI |
25 | Otto S, Sotlar K, Ehrenfeld M, Pautke C (2011) Osteonecrosis of the jaw as a possible rare side effect of annual bisphosphonate administration for osteoporosis: a case report. J Med Case Rep 5:477 DOI |
26 | Veronesi F, Torricelli P, Borsari V, Tschon M, Rimondini L, Fini M (2011) Mesenchymal stem cells in the aging and osteoporotic population. Crit Rev Eukar Gene 21:363-377 DOI |
27 | An J, Yang H, Zhang Q, Liu C, Zhao J, Zhang L, Chen B (2016) Natural products for treatment of osteoporosis: the effects and mechanisms on promoting osteoblast-mediated bone formation. Life Sci 147:46-58 DOI |
28 | Jia M, Nie Y, Cao DP, Xue YY, Wang JS, Zhao L, Rahman K, Zhang QY, Qin LP (2012) Potential antiosteoporotic agents from plants: a comprehensive review. Evid-Based Compl Alt 2012:364604 |
29 | Justesen J, Stenderup K, Ebbesen EN, Mosekilde L, Steiniche T, Kassem M (2001) Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis. Biogerontology 2:165-171 DOI |
30 | Al-Anazi AF, Qureshi VF, Javaid K, Qureshi S (2011) Preventive effects of phytoestrogens against postmenopausal osteoporosis as compared to the available therapeutic choices: an overview. J Nat Sci Biol Med 2:154-163 DOI |
31 | Bishop GB, Einhorn TA (2007) Current and future clinical applications of bone morphogenetic proteins in orthopaedic trauma surgery. Int Orthop 31:721-727 DOI |
32 | Komm BS, Chines AA (2012) An update on selective estrogen receptor modulators for the prevention and treatment of osteoporosis. Maturitas 71:221-226 DOI |
![]() |